Improving Hypertension Control in East and Central Harlem

Sponsor
Icahn School of Medicine at Mount Sinai (Other)
Overall Status
Completed
CT.gov ID
NCT00211666
Collaborator
Agency for Healthcare Research and Quality (AHRQ) (U.S. Fed)
480
1
47
10.2

Study Details

Study Description

Brief Summary

This hypertension project is evaluating strategies developed to target problems underlying lack of blood pressure control among treated but uncontrolled hypertensive patients in East and Central Harlem.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Nurse management, home blood pressure monitors, and a chronic disease self management course.
N/A

Detailed Description

The hypertension project will tailor improvement strategies to the problems identified as underlying underuse among treated but uncontrolled hypertensive patients in East and Central Harlem, New York City. Along with the communities' 6 major health providers, we will first combine qualitative and quantitative methods to identify specific patient, provider, and system problems, and customize interventions to address them. In a randomized controlled trial, we will then randomly assign 480 patients among 4 arms: nurse management, blood pressure monitors alone, usual care, and peer led chronic disease self-management course. During the 18-month trial, patients self-monitor their blood pressure or attend a self-management course, or nurse managers will assess patients' needs, counsel them, address any access barriers, and follow up with regular telephone contacts; convey information, including blood pressures from patients' self-monitoring, between patients and physicians to inform possible medication changes; and ameliorate any systems problems. We will assess differences in blood pressure reductions among the 4 arms as the primary outcome, and in quality of life, patient satisfaction, costs, and cost-effectiveness as secondary outcomes. The findings will provide new knowledge about the relationship between these changes and patient and clinician knowledge, attitudes, and behaviors. The educational course is designed to teach patients tools for managing their chronic illness which will empower them to improve their overall health and is specifically tailored for patients living with asymptomatic chronic illnesses and will emphasize communication with health care providers. In partnership with community organizations and the policymakers, we will disseminate successful findings within these communities and throughout the state and the nation.

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Improving the Delivery of Effective Care to Minorities
Study Start Date :
Sep 1, 2002
Study Completion Date :
Aug 1, 2006

Outcome Measures

Primary Outcome Measures

  1. Differences in blood pressure reduction among the four study arms. []

Secondary Outcome Measures

  1. Quality of life []

  2. patient satisfaction []

  3. costs []

  4. cost-effectiness []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

Male and female, English or Spanish speaking African American and/or Hispanic patients with uncontrolled hypertension who have been seen in either the Cardiology clinic, Internal Medicine Associates (IMA) or Geriatric clinic at least twice in a given year at least 18 years of age.

Exclusion Criteria:

This study is about hypertension control among African Americans and Hispanics, these are the ethnic groups with disparities in CVD that we want to improve so other races are excluded. The study is for adults with hypertension; therefore, we are excluding anyone who is under 18 years of age.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mount Sinai School of Medicine New York New York United States 10029

Sponsors and Collaborators

  • Icahn School of Medicine at Mount Sinai
  • Agency for Healthcare Research and Quality (AHRQ)

Investigators

  • Principal Investigator: Mark Chassin, MD, Icahn School of Medicine at Mount Sinai

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00211666
Other Study ID Numbers:
  • P01HS010859-05
  • 00-0053
First Posted:
Sep 21, 2005
Last Update Posted:
Sep 21, 2005
Last Verified:
Sep 1, 2005

Study Results

No Results Posted as of Sep 21, 2005